Dynamics of bone marrow changes in patients with chronic idiopathic myelofibrosis following allogeneic stem cell transplantation.
Scant knowledge exists about the dynamics of fibro-osteosclerotic bone marrow (BM) lesions and regeneration of hematopoiesis following allogeneic peripheral stem cell transplantation (SCT) in chronic idiopathic myelofibrosis. Therefore, an immunohistochemical and morphometric study was performed on BM biopsies in 20 patients before and at standardized intervals (days 30 through 384) following SCT. In responding patients, a total regression of the pretransplant increased fibrosis was completed in the posttransplant period after about six months, while the extent of osteosclerosis did not change significantly during observation time. The quantity of CD61+ megakaryocytes including precursors was strikingly variable after SCT and, by using planimetric methods, atypical microforms exhibiting a dysplastic aspect could be demonstrated. These anomalies may be responsible for posttransplant thrombocytopenia. CD34+ progenitor cells were increased before transplantation, however, their number declined rapidly to normal values in responding patients. Nucleated erythroid precursors revealed a decreased amount before and after SCT accounting for anemia. Large clusters of this cell lineage indicated an initial hematopoietic reconstitution comparable with the expansion of the neutrophil granulopoiesis. Proliferative activity and apoptosis showed an increase until one year after SCT that implied a still regenerating hematopoiesis in keeping with an enhanced cell turnover.
Thiele
J
J
Institute of Pathology, University of Cologne, Joseph-Stelzmannstrasse 9, D-50924 Cologne, Germany. j.thiele@uni-koeln.de
Kvasnicka
H M
HM
Dietrich
H
H
Stein
G
G
Hann
M
M
Kaminski
A
A
Rathjen
N
N
Metz
K A
KA
Beelen
D W
DW
Ditschkowski
M
M
Zander
A
A
Kroeger
N
N
D000293:Adolescent; D000328:Adult; D018952:Antigens, CD34 / Q000032:analysis; D001853:Bone Marrow / Q000737:chemistry / Q000473:pathology*; D001856:Bone Marrow Examination / Q000379:methods; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D039661:Integrin beta3 / Q000032:analysis; D019394:Ki-67 Antigen / Q000032:analysis; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation; D055728:Primary Myelofibrosis / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D011446:Prospective Studies; D016896:Treatment Outcome
D018952:Antigens, CD34; D039661:Integrin beta3; D019394:Ki-67 Antigen